{"abstracts-retrieval-response": {"item": {"ait:process-info": {"ait:status": {"@state": "update", "@type": "core", "@stage": "S300"}, "ait:date-delivered": {"@day": "29", "@year": "2024", "@timestamp": "2024-10-29T08:44:45.000045-04:00", "@month": "10"}, "ait:date-sort": {"@day": "01", "@year": "2017", "@month": "12"}}, "xocs:meta": {"xocs:funding-list": {"@pui-match": "primary", "@has-funding-info": "1", "xocs:funding": [{"xocs:funding-agency-matched-string": "Center of Excellence in Clinical Virology", "xocs:funding-id": "GCE 58-014-30-004"}, {"xocs:funding-agency-matched-string": "Chulalongkorn University and Hospital"}, {"xocs:funding-agency-matched-string": "Ratchadapiseksomphot Endowment Fund", "xocs:funding-id": [{"$": "RA55/024"}, {"$": "RA57/096"}, {"$": "RA57/109"}, {"$": "RA59/074"}, {"$": "SRP_05_55_30_01"}]}, {"xocs:funding-agency-matched-string": "National Science and Technology Development Agency", "xocs:funding-agency-acronym": "\u0e2a\u0e27\u0e17\u0e0a", "xocs:funding-agency": "National Science and Technology Development Agency", "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100004192", "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"}, {"xocs:funding-agency-matched-string": "Faculty of Medicine, Chulalongkorn University", "xocs:funding-agency-acronym": "MDCU", "xocs:funding-agency": "Faculty of Medicine, Chulalongkorn University", "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100004776", "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"}], "xocs:funding-addon-generated-timestamp": "2021-05-30T17:40:54.590Z", "xocs:funding-text": "P.K. and S.K. contributed to the study concept and design, conduct the trial, draft and wrote the manuscript. S.S. was involved in the experimental design and performed laboratory works. K.T. participated in the study concept and design. K.C. was involved in carrying out the protocol. P.T. performed laboratory works. C.C. contributed to the concept design and plan for the laboratory work. Y.P. was involved in the conception of the study and revised the draft. All authors read and approved the final manuscript. This work was supported by the Ratchadapiseksomphot Endowment Fund (RA55/024, RA57/096, RA57/109 and RA59/074); the \u201cGrant for Junior or Terminal Executive Staff\u201d (CU\u2019s SRP_05_55_30_01), Faculty of Medicine, Chulalongkorn University; The Research Chair Grant from the National Science and Technology Development Agency; and The Center of Excellence in Clinical Virology (GCE 58-014-30-004), Chulalongkorn University and Hospital, Bangkok, Thailand.", "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"}}, "bibrecord": {"head": {"author-group": [{"affiliation": {"country": "Thailand", "@afid": "60028190", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Division of Gastroenterology"}, {"$": "Department of Medicine"}, {"$": "Chulalongkorn University"}], "affiliation-id": {"@afid": "60028190", "@dptid": "113019942"}, "@dptid": "113019942"}, "author": [{"ce:given-name": "Piyawat", "preferred-name": {"ce:given-name": "Piyawat", "ce:initials": "P.", "ce:surname": "Komolmit", "ce:indexed-name": "Komolmit P."}, "@seq": "1", "ce:initials": "P.", "@_fa": "true", "@type": "auth", "ce:surname": "Komolmit", "@auid": "8685320500", "@orcid": "0000-0002-1357-9547", "ce:indexed-name": "Komolmit P."}, {"ce:given-name": "Sirinporn", "preferred-name": {"ce:given-name": "Sirinporn", "ce:initials": "S.", "ce:surname": "Suksawatamnuay", "ce:indexed-name": "Suksawatamnuay S."}, "@seq": "3", "ce:initials": "S.", "@_fa": "true", "@type": "auth", "ce:surname": "Suksawatamnuay", "@auid": "55599677800", "ce:indexed-name": "Suksawatamnuay S."}, {"ce:given-name": "Kessarin", "preferred-name": {"ce:given-name": "Kessarin", "ce:initials": "K.", "ce:surname": "Thanapirom", "ce:indexed-name": "Thanapirom K."}, "@seq": "4", "ce:initials": "K.", "@_fa": "true", "@type": "auth", "ce:surname": "Thanapirom", "@auid": "55325142600", "ce:indexed-name": "Thanapirom K."}, {"ce:given-name": "Panarat", "preferred-name": {"ce:given-name": "Panarat", "ce:initials": "P.", "ce:surname": "Thaimai", "ce:indexed-name": "Thaimai P."}, "@seq": "6", "ce:initials": "P.", "@_fa": "true", "@type": "auth", "ce:surname": "Thaimai", "@auid": "56904175400", "ce:indexed-name": "Thaimai P."}]}, {"affiliation": {"country": "Thailand", "@afid": "60022183", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Center of Excellence in Liver Diseases: King Chulalongkorn Memorial Hospital"}, {"$": "Thai Red Cross Society"}], "affiliation-id": [{"@afid": "60022183"}, {"@afid": "60031780"}]}, "author": [{"ce:given-name": "Piyawat", "preferred-name": {"ce:given-name": "Piyawat", "ce:initials": "P.", "ce:surname": "Komolmit", "ce:indexed-name": "Komolmit P."}, "@seq": "1", "ce:initials": "P.", "@_fa": "true", "@type": "auth", "ce:surname": "Komolmit", "@auid": "8685320500", "ce:indexed-name": "Komolmit P."}, {"ce:given-name": "Sirinporn", "preferred-name": {"ce:given-name": "Sirinporn", "ce:initials": "S.", "ce:surname": "Suksawatamnuay", "ce:indexed-name": "Suksawatamnuay S."}, "@seq": "3", "ce:initials": "S.", "@_fa": "true", "@type": "auth", "ce:surname": "Suksawatamnuay", "@auid": "55599677800", "ce:indexed-name": "Suksawatamnuay S."}, {"ce:given-name": "Kessarin", "preferred-name": {"ce:given-name": "Kessarin", "ce:initials": "K.", "ce:surname": "Thanapirom", "ce:indexed-name": "Thanapirom K."}, "@seq": "4", "ce:initials": "K.", "@_fa": "true", "@type": "auth", "ce:surname": "Thanapirom", "@auid": "55325142600", "ce:indexed-name": "Thanapirom K."}]}, {"affiliation": {"country": "Thailand", "@afid": "60022570", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Gastroenterology Unit"}, {"$": "Department of Medicine"}, {"$": "Lerdsin Hospital"}], "affiliation-id": {"@afid": "60022570", "@dptid": "104150954"}, "@dptid": "104150954"}, "author": [{"ce:given-name": "Sayamon", "preferred-name": {"ce:given-name": "Sayamon", "ce:initials": "S.", "ce:surname": "Kimtrakool", "ce:indexed-name": "Kimtrakool S."}, "@seq": "2", "ce:initials": "S.", "@_fa": "true", "@type": "auth", "ce:surname": "Kimtrakool", "@auid": "57195642727", "ce:indexed-name": "Kimtrakool S."}]}, {"affiliation": {"country": "Thailand", "@afid": "60014909", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Gastroenterology Unit"}, {"$": "Department of Medicine"}, {"$": "Taksin Hospital"}], "affiliation-id": {"@afid": "60014909", "@dptid": "103766983"}, "@dptid": "103766983"}, "author": [{"ce:given-name": "Kanita", "preferred-name": {"ce:given-name": "Kanita", "ce:initials": "K.", "ce:surname": "Chattrasophon", "ce:indexed-name": "Chattrasophon K."}, "@seq": "5", "ce:initials": "K.", "@_fa": "true", "@type": "auth", "ce:surname": "Chattrasophon", "@auid": "57195635953", "ce:indexed-name": "Chattrasophon K."}]}, {"affiliation": {"country": "Thailand", "@afid": "60028190", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Division of Immunology"}, {"$": "Department of Microbiology"}, {"$": "Chulalongkorn University"}], "affiliation-id": {"@afid": "60028190", "@dptid": "110210256"}, "@dptid": "110210256"}, "author": [{"ce:given-name": "Chintana", "preferred-name": {"ce:given-name": "Chintana", "ce:initials": "C.", "ce:surname": "Chirathaworn", "ce:indexed-name": "Chirathaworn C."}, "@seq": "7", "ce:initials": "C.", "@_fa": "true", "@type": "auth", "ce:surname": "Chirathaworn", "@auid": "6603113594", "ce:indexed-name": "Chirathaworn C."}]}, {"affiliation": {"country": "Thailand", "@afid": "60028190", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Center of Excellence in Clinical Virology"}, {"$": "Faculty of Medicine"}, {"$": "Chulalongkorn University"}], "affiliation-id": {"@afid": "60028190", "@dptid": "104425854"}, "@dptid": "104425854"}, "author": [{"ce:given-name": "Yong", "preferred-name": {"ce:given-name": "Yong", "ce:initials": "Y.", "ce:surname": "Poovorawan", "ce:indexed-name": "Poovorawan Y."}, "@seq": "8", "ce:initials": "Y.", "@date-locked": "2017-12-28T18:50:11.321", "@_fa": "true", "@type": "auth", "ce:surname": "Poovorawan", "@auid": "7102786191", "ce:indexed-name": "Poovorawan Y."}]}], "citation-title": "Vitamin D supplementation improves serum markers associated with hepatic fibrogenesis in chronic hepatitis C patients: A randomized, double-blind, placebo-controlled study", "abstracts": "\u00a9 2017 The Author(s).Hepatic fibrosis is the net accumulation of matrix tissue components which controlled by pro-fibrolytic enzymes, matrix metalloproteinases (MMPs), and pro-fibrotic cytokine, TGF-\u03b21, and enzymes, tissue inhibitors of MMPs (TIMPs). Vitamin D (VD) supplementation has been shown to reverse these processes in vitro and in vivo. This study sought to determine the effect of VD supplementation on serum fibrotic markers in chronic hepatitis C (CHC) patients. Fifty-four CHC patients with VD deficiency were randomized into two groups, a VD group (n = 29) and a placebo group (n = 29). The serum levels of 25-hydroxy VD, TGF-\u03b21, TIMP-1, MMP2 and MMP9 were measured at baseline and at the end of the 6-week study period. Upon correction of VD levels, TGF-\u03b21 and TIMP-1 levels were decreased, and the MMP2 and MMP9 levels were significantly increased in the VD group. A comparison of the mean changes (delta) in the markers between groups showed that TGF-\u03b21 and TIMP-1 levels were significantly decreased and the MMP2 and MMP9 were significantly higher in the VD group than in the placebo group. By using CHC patients as a model, this study provides additional evidence that VD plays an important role in the reversal of hepatic fibrogenesis.", "correspondence": {"affiliation": {"country": "Thailand", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Division of Gastroenterology"}, {"$": "Department of Medicine"}, {"$": "Chulalongkorn University"}]}, "person": {"ce:given-name": "Piyawat", "ce:initials": "P.", "ce:surname": "Komolmit", "ce:indexed-name": "Komolmit P."}}, "citation-info": {"citation-type": {"@code": "ar"}, "citation-language": {"@language": "English", "@xml:lang": "eng"}, "abstract-language": {"@language": "English", "@xml:lang": "eng"}}, "source": {"website": {"ce:e-address": {"$": "www.nature.com/srep/index.html", "@type": "email"}}, "translated-sourcetitle": {"$": "Scientific Reports", "@xml:lang": "eng"}, "volisspag": {"voliss": {"@volume": "7", "@issue": "1"}}, "@type": "j", "sourcetitle": "Scientific Reports", "publicationdate": {"month": "12", "year": "2017", "date-text": {"@xfab-added": "true", "$": "1 December 2017"}, "day": "01"}, "sourcetitle-abbrev": "Sci. Rep.", "@country": "gbr", "issn": {"$": "20452322", "@type": "electronic"}, "publicationyear": {"@first": "2017"}, "publisher": {"affiliation": {"address-part": "Houndmills", "postal-code": "RG21 6XS", "@country": "gbr", "city": "Basingstoke, Hampshire"}, "publishername": "Nature Publishing Group"}, "article-number": "8905", "@srcid": "21100200805"}, "enhancement": {"classificationgroup": {"classifications": [{"@type": "ASJC", "classification": "1000"}, {"@type": "SUBJABBR", "classification": "MULT"}]}, "chemicalgroup": {"chemicals": {"@source": "nlm", "chemical": [{"chemical-name": "25-hydroxyvitamin D"}, {"chemical-name": "Biomarkers"}, {"chemical-name": "TGFB1 protein, human"}, {"chemical-name": "Transforming Growth Factor beta1"}, {"chemical-name": "Vitamin D"}]}}}}, "item-info": {"copyright": {"$": "Copyright 2017 Elsevier B.V., All rights reserved.", "@type": "Elsevier"}, "dbcollection": [{"$": "NURSNG"}, {"$": "REAXYSCAR"}, {"$": "SCOPUS"}, {"$": "SNSOC"}, {"$": "Scopusbase"}, {"$": "MEDL"}], "history": {"date-created": {"@day": "20", "@year": "2017", "@timestamp": "BST 05:14:24", "@month": "09"}}, "itemidlist": {"itemid": [{"$": "618265357", "@idtype": "PUI"}, {"$": "693606499", "@idtype": "CAR-ID"}, {"$": "2017317645", "@idtype": "NURSNG"}, {"$": "20171642472", "@idtype": "REAXYSCAR"}, {"$": "20170458718", "@idtype": "SCOPUS"}, {"$": "2017105511", "@idtype": "SNSOC"}, {"$": "85029406786", "@idtype": "SCP"}, {"$": "85029406786", "@idtype": "SGR"}, {"$": "626582557", "@idtype": "PUIsecondary"}, {"$": "28827788", "@idtype": "MEDL"}], "ce:doi": "10.1038/s41598-017-09512-7"}}, "tail": {"bibliography": {"@refcount": "42", "reference": [{"ref-fulltext": "Lee, Y. A., Wallace, M. C. & Friedman, S. L. Pathobiology of liver fibrosis: a translational success story. Gut 64, 830-841, doi:10.1136/gutjnl-2014-306842 (2015).", "@id": "1", "ref-info": {"ref-publicationyear": {"@first": "2015"}, "ref-title": {"ref-titletext": "Pathobiology of liver fibrosis: A translational success story"}, "refd-itemidlist": {"itemid": [{"$": "10.1136/gutjnl-2014-306842", "@idtype": "DOI"}, {"$": "84928898387", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "64"}, "pagerange": {"@first": "830", "@last": "841"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "Y.A.", "@_fa": "true", "ce:surname": "Lee", "ce:indexed-name": "Lee Y.A."}, {"@seq": "2", "ce:initials": "M.C.", "@_fa": "true", "ce:surname": "Wallace", "ce:indexed-name": "Wallace M.C."}, {"@seq": "3", "ce:initials": "S.L.", "@_fa": "true", "ce:surname": "Friedman", "ce:indexed-name": "Friedman S.L."}]}, "ref-sourcetitle": "Gut"}}, {"ref-fulltext": "Wynn, T. A. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. The Journal of clinical investigation 117, 524-529, doi:10.1172/jci31487 (2007).", "@id": "2", "ref-info": {"ref-publicationyear": {"@first": "2007"}, "ref-title": {"ref-titletext": "Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases"}, "refd-itemidlist": {"itemid": [{"$": "10.1172/jci31487", "@idtype": "DOI"}, {"$": "33847350691", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "117"}, "pagerange": {"@first": "524", "@last": "529"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "T.A.", "@_fa": "true", "ce:surname": "Wynn", "ce:indexed-name": "Wynn T.A."}]}, "ref-sourcetitle": "The Journal of Clinical Investigation"}}, {"ref-fulltext": "Stanaway, J. D. et al. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet (London, England) 388, 1081-1088, doi:10.1016/s0140-6736(16)30579-7 (2016).", "@id": "3", "ref-info": {"ref-publicationyear": {"@first": "2016"}, "ref-title": {"ref-titletext": "The global burden of viral hepatitis from 1990 to 2013: Findings from the Global Burden of Disease Study 2013"}, "refd-itemidlist": {"itemid": [{"$": "10.1016/s0140-6736(16)30579-7", "@idtype": "DOI"}, {"$": "84983671799", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "388"}, "pagerange": {"@first": "1081", "@last": "1088"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.D.", "@_fa": "true", "ce:surname": "Stanaway", "ce:indexed-name": "Stanaway J.D."}], "et-al": null}, "ref-sourcetitle": "Lancet (London, England)"}}, {"ref-fulltext": "Arteh, J., Narra, S. & Nair, S. Prevalence of vitamin D deficiency in chronic liver disease. Digestive diseases and sciences 55, 2624-2628, doi:10.1007/s10620-009-1069-9 (2010).", "@id": "4", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Prevalence of Vitamin D deficiency in chronic liver disease"}, "refd-itemidlist": {"itemid": [{"$": "10.1007/s10620-009-1069-9", "@idtype": "DOI"}, {"$": "77956189184", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "55"}, "pagerange": {"@first": "2624", "@last": "2628"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Arteh", "ce:indexed-name": "Arteh J."}, {"@seq": "2", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Narra", "ce:indexed-name": "Narra S."}, {"@seq": "3", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Nair", "ce:indexed-name": "Nair S."}]}, "ref-sourcetitle": "Digestive Diseases and Sciences"}}, {"ref-fulltext": "Malham, M. et al. Vitamin D deficiency in cirrhosis relates to liver dysfunction rather than aetiology. World journal of gastroenterology: WJG 17, 922-925, doi:10.3748/wjg.v17.i7.922 (2011).", "@id": "5", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "Vitamin D deficiency in cirrhosis relates to liver dysfunction rather than aetiology"}, "refd-itemidlist": {"itemid": [{"$": "10.3748/wjg.v17.i7.922", "@idtype": "DOI"}, {"$": "79955931061", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "17"}, "pagerange": {"@first": "922", "@last": "925"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Malham", "ce:indexed-name": "Malham M."}], "et-al": null}, "ref-sourcetitle": "World Journal of Gastroenterology: WJG"}}, {"ref-fulltext": "Venu, M., Martin, E., Saeian, K. & Gawrieh, S. High prevalence of vitamin A deficiency and vitamin D deficiency in patients evaluated for liver transplantation. Liver transplantation: official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 19, 627-633, doi:10.1002/lt.23646 (2013).", "@id": "6", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "High prevalence of Vitamin A deficiency and Vitamin D deficiency in patients evaluated for liver transplantation"}, "refd-itemidlist": {"itemid": [{"$": "10.1002/lt.23646", "@idtype": "DOI"}, {"$": "84878268778", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "19"}, "pagerange": {"@first": "627", "@last": "633"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Venu", "ce:indexed-name": "Venu M."}, {"@seq": "2", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Martin", "ce:indexed-name": "Martin E."}, {"@seq": "3", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Saeian", "ce:indexed-name": "Saeian K."}, {"@seq": "4", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Gawrieh", "ce:indexed-name": "Gawrieh S."}]}, "ref-sourcetitle": "Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society"}}, {"ref-fulltext": "Petta, S. et al. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology (Baltimore, Md.) 51, 1158-1167, doi:10.1002/hep.23489 (2010).", "@id": "7", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Low Vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C"}, "refd-itemidlist": {"itemid": [{"$": "10.1002/hep.23489", "@idtype": "DOI"}, {"$": "77950624679", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "51"}, "pagerange": {"@first": "1158", "@last": "1167"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Petta", "ce:indexed-name": "Petta S."}], "et-al": null}, "ref-sourcetitle": "Hepatology (Baltimore, Md.)"}}, {"ref-fulltext": "Lange, C. M. et al. Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy. Journal of hepatology 54, 887-893, doi:10.1016/j.jhep.2010.08.036 (2011).", "@id": "8", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy"}, "refd-itemidlist": {"itemid": [{"$": "10.1016/j.jhep.2010.08.036", "@idtype": "DOI"}, {"$": "79954669573", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "54"}, "pagerange": {"@first": "887", "@last": "893"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "C.M.", "@_fa": "true", "ce:surname": "Lange", "ce:indexed-name": "Lange C.M."}], "et-al": null}, "ref-sourcetitle": "Journal of Hepatology"}}, {"ref-fulltext": "Garcia-Alvarez, M. et al. Relationship of vitamin D status with advanced liver fibrosis and response to hepatitis C virus therapy: a meta-analysis. Hepatology (Baltimore, Md.) 60, 1541-1550, doi:10.1002/hep.27281 (2014).", "@id": "9", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "Relationship of Vitamin D status with advanced liver fibrosis and response to hepatitis C virus therapy: A meta-analysis"}, "refd-itemidlist": {"itemid": [{"$": "10.1002/hep.27281", "@idtype": "DOI"}, {"$": "84919970559", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "60"}, "pagerange": {"@first": "1541", "@last": "1550"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Garcia-Alvarez", "ce:indexed-name": "Garcia-Alvarez M."}], "et-al": null}, "ref-sourcetitle": "Hepatology (Baltimore, Md.)"}}, {"ref-fulltext": "Ko, B. J. et al. Relationship between 25-Hydroxyvitamin D Levels and Liver Fibrosis as Assessed by Transient Elastography in Patients with Chronic Liver Disease. Gut and liver 10, 818-825, doi:10.5009/gnl15331 (2016).", "@id": "10", "ref-info": {"ref-publicationyear": {"@first": "2016"}, "ref-title": {"ref-titletext": "Relationship between 25-hydroxyvitamin d levels and liver fibrosis as assessed by transient elastography in patients with chronic liver disease"}, "refd-itemidlist": {"itemid": [{"$": "10.5009/gnl15331", "@idtype": "DOI"}, {"$": "84990053602", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "10"}, "pagerange": {"@first": "818", "@last": "825"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "B.J.", "@_fa": "true", "ce:surname": "Ko", "ce:indexed-name": "Ko B.J."}], "et-al": null}, "ref-sourcetitle": "Gut and Liver"}}, {"ref-fulltext": "Holick, M. F. Vitamin D deficiency. The New England journal of medicine 357, 266-281, doi:10.1056/NEJMra070553 (2007).", "@id": "11", "ref-info": {"ref-publicationyear": {"@first": "2007"}, "ref-title": {"ref-titletext": "Vitamin D deficiency"}, "refd-itemidlist": {"itemid": [{"$": "10.1056/NEJMra070553", "@idtype": "DOI"}, {"$": "34447514029", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "357"}, "pagerange": {"@first": "266", "@last": "281"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.F.", "@_fa": "true", "ce:surname": "Holick", "ce:indexed-name": "Holick M.F."}]}, "ref-sourcetitle": "The New England Journal of Medicine"}}, {"ref-fulltext": "Beilfuss, A. et al. Vitamin D counteracts fibrogenic TGF-beta signalling in human hepatic stellate cells both receptor-dependently and independently. Gut 64, 791-799, doi:10.1136/gutjnl-2014-307024 (2015).", "@id": "12", "ref-info": {"ref-publicationyear": {"@first": "2015"}, "ref-title": {"ref-titletext": "Vitamin D counteracts fibrogenic TGF-beta signalling in human hepatic stellate cells both receptor-dependently and independently"}, "refd-itemidlist": {"itemid": [{"$": "10.1136/gutjnl-2014-307024", "@idtype": "DOI"}, {"$": "84928883882", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "64"}, "pagerange": {"@first": "791", "@last": "799"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Beilfuss", "ce:indexed-name": "Beilfuss A."}], "et-al": null}, "ref-sourcetitle": "Gut"}}, {"ref-fulltext": "Ding, N. et al. A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. Cell 153, 601-613, doi:10.1016/j. cell.2013.03.028 (2013).", "@id": "13", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "A Vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response"}, "refd-itemidlist": {"itemid": [{"$": "10.1016/j.cell.2013.03.028", "@idtype": "DOI"}, {"$": "84876928036", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "153"}, "pagerange": {"@first": "601", "@last": "613"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Ding", "ce:indexed-name": "Ding N."}], "et-al": null}, "ref-sourcetitle": "Cell"}}, {"ref-fulltext": "Grunhage, F. et al. Common genetic variation in vitamin D metabolism is associated with liver stiffness. Hepatology (Baltimore, Md.) 56, 1883-1891, doi:10.1002/hep.25830 (2012).", "@id": "14", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Common genetic variation in Vitamin D metabolism is associated with liver stiffness"}, "refd-itemidlist": {"itemid": [{"$": "10.1002/hep.25830", "@idtype": "DOI"}, {"$": "84868198010", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "56"}, "pagerange": {"@first": "1883", "@last": "1891"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Grunhage", "ce:indexed-name": "Grunhage F."}], "et-al": null}, "ref-sourcetitle": "Hepatology (Baltimore, Md.)"}}, {"ref-fulltext": "Baur, K. et al. Combined effect of 25-OH vitamin D plasma levels and genetic vitamin D receptor (NR 1I1) variants on fibrosis progression rate in HCV patients. Liver international: official journal of the International Association for the Study of the Liver 32, 635-643, doi:10.1111/j.1478-3231.2011.02674.x (2012).", "@id": "15", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Combined effect of 25-OH Vitamin D plasma levels and genetic Vitamin D receptor (NR 1I1) variants on fibrosis progression rate in HCV patients"}, "refd-itemidlist": {"itemid": [{"$": "10.1111/j.1478-3231.2011.02674.x", "@idtype": "DOI"}, {"$": "84858281844", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "32"}, "pagerange": {"@first": "635", "@last": "643"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Baur", "ce:indexed-name": "Baur K."}], "et-al": null}, "ref-sourcetitle": "Liver International: Official Journal of the International Association for the Study of the Liver"}}, {"ref-fulltext": "Wahsh, E., Abu-Elsaad, N., El-Karef, A. & Ibrahim, T. The vitamin D receptor agonist, calcipotriol, modulates fibrogenic pathways mitigating liver fibrosis in-vivo: An experimental study. European journal of pharmacology 789, 362-369, doi:10.1016/j. ejphar.2016.07.052 (2016).", "@id": "16", "ref-info": {"ref-publicationyear": {"@first": "2016"}, "ref-title": {"ref-titletext": "The Vitamin D receptor agonist, calcipotriol, modulates fibrogenic pathways mitigating liver fibrosis in-vivo: An experimental study"}, "refd-itemidlist": {"itemid": [{"$": "10.1016/j.ejphar.2016.07.052", "@idtype": "DOI"}, {"$": "84980318182", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "789"}, "pagerange": {"@first": "362", "@last": "369"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Wahsh", "ce:indexed-name": "Wahsh E."}, {"@seq": "2", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Abu-Elsaad", "ce:indexed-name": "Abu-Elsaad N."}, {"@seq": "3", "ce:initials": "A.", "@_fa": "true", "ce:surname": "El-Karef", "ce:indexed-name": "El-Karef A."}, {"@seq": "4", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Ibrahim", "ce:indexed-name": "Ibrahim T."}]}, "ref-sourcetitle": "European Journal of Pharmacology"}}, {"ref-fulltext": "El-Maouche, D. et al. Vitamin D deficiency and its relation to bone mineral density and liver fibrosis in HIV-HCV coinfection. Antiviral therapy 18, 237-242, doi:10.3851/imp2264 (2013).", "@id": "17", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Vitamin D deficiency and its relation to bone mineral density and liver fibrosis in HIV-HCV coinfection"}, "refd-itemidlist": {"itemid": [{"$": "10.3851/imp2264", "@idtype": "DOI"}, {"$": "84875656279", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "18"}, "pagerange": {"@first": "237", "@last": "242"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "D.", "@_fa": "true", "ce:surname": "El-Maouche", "ce:indexed-name": "El-Maouche D."}], "et-al": null}, "ref-sourcetitle": "Antiviral Therapy"}}, {"ref-fulltext": "Kitson, M. T. et al. Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection. Journal of hepatology 58, 467-472, doi:10.1016/j.jhep.2012.11.017 (2013).", "@id": "18", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection"}, "refd-itemidlist": {"itemid": [{"$": "10.1016/j.jhep.2012.11.017", "@idtype": "DOI"}, {"$": "84874110697", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "58"}, "pagerange": {"@first": "467", "@last": "472"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.T.", "@_fa": "true", "ce:surname": "Kitson", "ce:indexed-name": "Kitson M.T."}], "et-al": null}, "ref-sourcetitle": "Journal of Hepatology"}}, {"ref-fulltext": "Nobili, V. & Reif, S. Vitamin D and liver fibrosis: let's start soon before it's too late. Gut 64, 698-699, doi:10.1136/gutjnl-2014-308175 (2015).", "@id": "19", "ref-info": {"ref-publicationyear": {"@first": "2015"}, "ref-title": {"ref-titletext": "Vitamin D and liver fibrosis: Let's start soon before it's too late"}, "refd-itemidlist": {"itemid": [{"$": "10.1136/gutjnl-2014-308175", "@idtype": "DOI"}, {"$": "84929462486", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "64"}, "pagerange": {"@first": "698", "@last": "699"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "V.", "@_fa": "true", "ce:surname": "Nobili", "ce:indexed-name": "Nobili V."}, {"@seq": "2", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Reif", "ce:indexed-name": "Reif S."}]}, "ref-sourcetitle": "Gut"}}, {"ref-fulltext": "Pinzani, M. Pathophysiology of Liver Fibrosis. Digestive diseases (Basel, Switzerland). 33, 492-497, doi:10.1159/000374096 (2015).", "@id": "20", "ref-info": {"ref-publicationyear": {"@first": "2015"}, "ref-title": {"ref-titletext": "Pathophysiology of liver fibrosis"}, "refd-itemidlist": {"itemid": [{"$": "10.1159/000374096", "@idtype": "DOI"}, {"$": "84937399899", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "33"}, "pagerange": {"@first": "492", "@last": "497"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Pinzani", "ce:indexed-name": "Pinzani M."}]}, "ref-sourcetitle": "Digestive Diseases (Basel, Switzerland)."}}, {"ref-fulltext": "Petta, S. et al. Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients. Journal of viral hepatitis 20, 486-493, doi:10.1111/jvh.12072 (2013).", "@id": "21", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Association of Vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients"}, "refd-itemidlist": {"itemid": [{"$": "10.1111/jvh.12072", "@idtype": "DOI"}, {"$": "84878575439", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "20"}, "pagerange": {"@first": "486", "@last": "493"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Petta", "ce:indexed-name": "Petta S."}], "et-al": null}, "ref-sourcetitle": "Journal of Viral Hepatitis"}}, {"ref-fulltext": "Terrier, B. et al. Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis. Journal of hepatology 55, 756-761, doi:10.1016/j.jhep.2011.01.041 (2011).", "@id": "22", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "Low 25-OH Vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis"}, "refd-itemidlist": {"itemid": [{"$": "10.1016/j.jhep.2011.01.041", "@idtype": "DOI"}, {"$": "79959293590", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "55"}, "pagerange": {"@first": "756", "@last": "761"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Terrier", "ce:indexed-name": "Terrier B."}], "et-al": null}, "ref-sourcetitle": "Journal of Hepatology"}}, {"ref-fulltext": "Lindor, K. D. et al. Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial. Hepatology (Baltimore, Md.) 39, 770-778, doi:10.1002/hep.20092 (2004).", "@id": "23", "ref-info": {"ref-publicationyear": {"@first": "2004"}, "ref-title": {"ref-titletext": "Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized trial"}, "refd-itemidlist": {"itemid": [{"$": "10.1002/hep.20092", "@idtype": "DOI"}, {"$": "1542515099", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "39"}, "pagerange": {"@first": "770", "@last": "778"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "K.D.", "@_fa": "true", "ce:surname": "Lindor", "ce:indexed-name": "Lindor K.D."}], "et-al": null}, "ref-sourcetitle": "Hepatology (Baltimore, Md.)"}}, {"ref-fulltext": "Sanyal, A. J. et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. The New England journal of medicine 362, 1675-1685, doi:10.1056/NEJMoa0907929 (2010).", "@id": "24", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Pioglitazone, Vitamin E, or placebo for nonalcoholic steatohepatitis"}, "refd-itemidlist": {"itemid": [{"$": "10.1056/NEJMoa0907929", "@idtype": "DOI"}, {"$": "77951874018", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "362"}, "pagerange": {"@first": "1675", "@last": "1685"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.J.", "@_fa": "true", "ce:surname": "Sanyal", "ce:indexed-name": "Sanyal A.J."}], "et-al": null}, "ref-sourcetitle": "The New England Journal of Medicine"}}, {"ref-fulltext": "Curry, M. P. et al. Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis. The New England journal of medicine 373, 2618-2628, doi:10.1056/NEJMoa1512614 (2015).", "@id": "25", "ref-info": {"ref-publicationyear": {"@first": "2015"}, "ref-title": {"ref-titletext": "Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis"}, "refd-itemidlist": {"itemid": [{"$": "10.1056/NEJMoa1512614", "@idtype": "DOI"}, {"$": "84952931354", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "373"}, "pagerange": {"@first": "2618", "@last": "2628"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.P.", "@_fa": "true", "ce:surname": "Curry", "ce:indexed-name": "Curry M.P."}], "et-al": null}, "ref-sourcetitle": "The New England Journal of Medicine"}}, {"ref-fulltext": "Koh, C. et al. Long-term outcome of chronic hepatitis C after sustained virological response to interferon-based therapy. Alimentary pharmacology & therapeutics 37, 887-894, doi:10.1111/apt.12273 (2013).", "@id": "26", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Long-term outcome of chronic hepatitis C after sustained virological response to interferon-based therapy"}, "refd-itemidlist": {"itemid": [{"$": "10.1111/apt.12273", "@idtype": "DOI"}, {"$": "84875863023", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "37"}, "pagerange": {"@first": "887", "@last": "894"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Koh", "ce:indexed-name": "Koh C."}], "et-al": null}, "ref-sourcetitle": "Alimentary Pharmacology & Therapeutics"}}, {"ref-fulltext": "Marcellin, P. et al. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year openlabel follow-up study. Lancet (London, England) 381, 468-475, doi:10.1016/s0140-6736(12)61425-1 (2013).", "@id": "27", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: A 5-year openlabel follow-up study"}, "refd-itemidlist": {"itemid": [{"$": "10.1016/s0140-6736(12)61425-1", "@idtype": "DOI"}, {"$": "84873726484", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "381"}, "pagerange": {"@first": "468", "@last": "475"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Marcellin", "ce:indexed-name": "Marcellin P."}], "et-al": null}, "ref-sourcetitle": "Lancet (London, England)"}}, {"ref-fulltext": "EASL Recommendations on Treatment of Hepatitis C 2016. Journal of hepatology 66, 153-194, doi:10.1016/j.jhep.2016.09.001 (2017).", "@id": "28", "ref-info": {"ref-publicationyear": {"@first": "2017"}, "refd-itemidlist": {"itemid": [{"$": "10.1016/j.jhep.2016.09.001", "@idtype": "DOI"}, {"$": "84997285873", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "66"}, "pagerange": {"@first": "153", "@last": "194"}}, "ref-text": "EASL Recommendations on Treatment of Hepatitis C 2016", "ref-sourcetitle": "Journal of Hepatology"}}, {"ref-fulltext": "Gascon-Barre, M. et al. The normal liver harbors the vitamin D nuclear receptor in nonparenchymal and biliary epithelial cells. Hepatology (Baltimore, Md.) 37, 1034-1042, doi:10.1053/jhep.2003.50176 (2003).", "@id": "29", "ref-info": {"ref-publicationyear": {"@first": "2003"}, "ref-title": {"ref-titletext": "The normal liver harbors the Vitamin D nuclear receptor in nonparenchymal and biliary epithelial cells"}, "refd-itemidlist": {"itemid": [{"$": "10.1053/jhep.2003.50176", "@idtype": "DOI"}, {"$": "0038713221", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "37"}, "pagerange": {"@first": "1034", "@last": "1042"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Gascon-Barre", "ce:indexed-name": "Gascon-Barre M."}], "et-al": null}, "ref-sourcetitle": "Hepatology (Baltimore, Md.)"}}, {"ref-fulltext": "Abramovitch, S. et al. Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats. Gut 60, 1728-1737, doi:10.1136/gut.2010.234666 (2011).", "@id": "30", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats"}, "refd-itemidlist": {"itemid": [{"$": "10.1136/gut.2010.234666", "@idtype": "DOI"}, {"$": "80655127773", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "60"}, "pagerange": {"@first": "1728", "@last": "1737"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Abramovitch", "ce:indexed-name": "Abramovitch S."}], "et-al": null}, "ref-sourcetitle": "Gut"}}, {"ref-fulltext": "Abdelghany, A. H., BaSalamah, M. A., Idris, S., Ahmad, J. & Refaat, B. The fibrolytic potentials of vitamin D and thymoquinone remedial therapies: insights from liver fibrosis established by CCl4 in rats. Journal of translational medicine 14, 281, doi:10.1186/ s12967-016-1040-4 (2016).", "@id": "31", "ref-info": {"ref-publicationyear": {"@first": "2016"}, "ref-title": {"ref-titletext": "The fibrolytic potentials of Vitamin D and thymoquinone remedial therapies: Insights from liver fibrosis established by CCl4 in rats"}, "refd-itemidlist": {"itemid": [{"$": "10.1186/s12967-016-1040-4", "@idtype": "DOI"}, {"$": "84989332677", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "14"}, "pagerange": {"@first": "281"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.H.", "@_fa": "true", "ce:surname": "Abdelghany", "ce:indexed-name": "Abdelghany A.H."}, {"@seq": "2", "ce:initials": "M.A.", "@_fa": "true", "ce:surname": "BaSalamah", "ce:indexed-name": "BaSalamah M.A."}, {"@seq": "3", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Idris", "ce:indexed-name": "Idris S."}, {"@seq": "4", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Ahmad", "ce:indexed-name": "Ahmad J."}, {"@seq": "5", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Refaat", "ce:indexed-name": "Refaat B."}]}, "ref-sourcetitle": "Journal of Translational Medicine"}}, {"ref-fulltext": "Tsushima, H. et al. Reduced plasma transforming growth factor-beta1 levels in patients with chronic hepatitis C after interferonalpha therapy: association with regression of hepatic fibrosis. Journal of hepatology 30, 1-7 (1999).", "@id": "32", "ref-info": {"ref-publicationyear": {"@first": "1999"}, "ref-title": {"ref-titletext": "Reduced plasma transforming growth factor-beta1 levels in patients with chronic hepatitis C after interferonalpha therapy: Association with regression of hepatic fibrosis"}, "refd-itemidlist": {"itemid": {"$": "0032955814", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "30"}, "pagerange": {"@first": "1", "@last": "7"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Tsushima", "ce:indexed-name": "Tsushima H."}], "et-al": null}, "ref-sourcetitle": "Journal of Hepatology"}}, {"ref-fulltext": "Ramachandran, P. et al. Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis. Proceedings of the National Academy of Sciences of the United States of America 109, E3186-3195, doi:10.1073/pnas.1119964109 (2012).", "@id": "33", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis"}, "refd-itemidlist": {"itemid": [{"$": "10.1073/pnas.1119964109", "@idtype": "DOI"}, {"$": "84869208905", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "109"}, "pagerange": {"@first": "E3186", "@last": "E3195"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Ramachandran", "ce:indexed-name": "Ramachandran P."}], "et-al": null}, "ref-sourcetitle": "Proceedings of the National Academy of Sciences of the United States of America"}}, {"ref-fulltext": "Pellicoro, A., Ramachandran, P., Iredale, J. P. & Fallowfield, J. A. Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nature reviews. Immunology 14, 181-194, doi:10.1038/nri3623 (2014).", "@id": "34", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "Liver fibrosis and repair: Immune regulation of wound healing in a solid organ"}, "refd-itemidlist": {"itemid": [{"$": "10.1038/nri3623", "@idtype": "DOI"}, {"$": "84896806249", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "14"}, "pagerange": {"@first": "181", "@last": "194"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Pellicoro", "ce:indexed-name": "Pellicoro A."}, {"@seq": "2", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Ramachandran", "ce:indexed-name": "Ramachandran P."}, {"@seq": "3", "ce:initials": "J.P.", "@_fa": "true", "ce:surname": "Iredale", "ce:indexed-name": "Iredale J.P."}, {"@seq": "4", "ce:initials": "J.A.", "@_fa": "true", "ce:surname": "Fallowfield", "ce:indexed-name": "Fallowfield J.A."}]}, "ref-sourcetitle": "Nature Reviews. Immunology"}}, {"ref-fulltext": "Trocme, C. et al. Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared with MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon-alpha and ribavirin. Journal of viral hepatitis 13, 643-651, doi:10.1111/j.1365-2893.2006.00730.x (2006).", "@id": "35", "ref-info": {"ref-publicationyear": {"@first": "2006"}, "ref-title": {"ref-titletext": "Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared with MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon-alpha and ribavirin"}, "refd-itemidlist": {"itemid": [{"$": "10.1111/j.1365-2893.2006.00730.x", "@idtype": "DOI"}, {"$": "33748752028", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "13"}, "pagerange": {"@first": "643", "@last": "651"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Trocme", "ce:indexed-name": "Trocme C."}], "et-al": null}, "ref-sourcetitle": "Journal of Viral Hepatitis"}}, {"ref-fulltext": "Leroy, V. et al. Circulating Matrix Metalloproteinases 1, 2, 9 and Their Inhibitors TIMP-1 and TIMP-2 as Serum Markers of Liver Fibrosis in Patients With Chronic Hepatitis C: Comparison With PIIINP and Hyaluronic Acid. The American journal of gastroenterology 99, 271-279, doi:10.1111/j.1572-0241.2004.04055.x (2004).", "@id": "36", "ref-info": {"ref-publicationyear": {"@first": "2004"}, "ref-title": {"ref-titletext": "Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: Comparison with PIIINP and hyaluronic acid"}, "refd-itemidlist": {"itemid": [{"$": "10.1111/j.1572-0241.2004.04055.x", "@idtype": "DOI"}, {"$": "1442301501", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "99"}, "pagerange": {"@first": "271", "@last": "279"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "V.", "@_fa": "true", "ce:surname": "Leroy", "ce:indexed-name": "Leroy V."}], "et-al": null}, "ref-sourcetitle": "The American Journal of Gastroenterology"}}, {"ref-fulltext": "Matsumura, T. et al. 25-Hydroxyvitamin D3 suppresses hepatitis C virus production. Hepatology (Baltimore, Md.) 56, 1231-1239, doi:10.1002/hep.25763 (2012).", "@id": "37", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "25-Hydroxyvitamin D3 suppresses hepatitis C virus production"}, "refd-itemidlist": {"itemid": [{"$": "10.1002/hep.25763", "@idtype": "DOI"}, {"$": "84867162487", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "56"}, "pagerange": {"@first": "1231", "@last": "1239"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Matsumura", "ce:indexed-name": "Matsumura T."}], "et-al": null}, "ref-sourcetitle": "Hepatology (Baltimore, Md.)"}}, {"ref-fulltext": "Holick, M. F. et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. The Journal of clinical endocrinology and metabolism 96, 1911-1930, doi:10.1210/jc.2011-0385 (2011).", "@id": "38", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "Evaluation, treatment, and prevention of Vitamin D deficiency: An Endocrine Society clinical practice guideline"}, "refd-itemidlist": {"itemid": [{"$": "10.1210/jc.2011-0385", "@idtype": "DOI"}, {"$": "79960104336", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "96"}, "pagerange": {"@first": "1911", "@last": "1930"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.F.", "@_fa": "true", "ce:surname": "Holick", "ce:indexed-name": "Holick M.F."}], "et-al": null}, "ref-sourcetitle": "The Journal of Clinical Endocrinology and Metabolism"}}, {"ref-fulltext": "Moher, D. et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ (Clinical research ed.) 340, c869, doi:10.1136/bmj.c869 (2010).", "@id": "39", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials"}, "refd-itemidlist": {"itemid": [{"$": "10.1136/bmj.c869", "@idtype": "DOI"}, {"$": "77950273246", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "340"}, "pagerange": {"@first": "c869"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Moher", "ce:indexed-name": "Moher D."}], "et-al": null}, "ref-sourcetitle": "BMJ (Clinical Research Ed.)"}}, {"ref-fulltext": "Marek, B. et al. TGF-beta1 mRNA expression in liver biopsy specimens and TGF-beta1 serum levels in patients with chronic hepatitis C before and after antiviral therapy. Journal of clinical pharmacy and therapeutics 30, 271-277, doi:10.1111/j.1365-2710.2005.00644.x (2005).", "@id": "40", "ref-info": {"ref-publicationyear": {"@first": "2005"}, "ref-title": {"ref-titletext": "TGF-beta1 mRNA expression in liver biopsy specimens and TGF-beta1 serum levels in patients with chronic hepatitis C before and after antiviral therapy"}, "refd-itemidlist": {"itemid": [{"$": "10.1111/j.1365-2710.2005.00644.x", "@idtype": "DOI"}, {"$": "23844519824", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "30"}, "pagerange": {"@first": "271", "@last": "277"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Marek", "ce:indexed-name": "Marek B."}], "et-al": null}, "ref-sourcetitle": "Journal of Clinical Pharmacy and Therapeutics"}}, {"ref-fulltext": "Dupont, W. D. & Plummer, W. D. Jr. Power and sample size calculations for studies involving linear regression. Controlled clinical trials 19, 589-601 (1998).", "@id": "41", "ref-info": {"ref-publicationyear": {"@first": "1998"}, "ref-title": {"ref-titletext": "Power and sample size calculations for studies involving linear regression"}, "refd-itemidlist": {"itemid": {"$": "0032430986", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "19"}, "pagerange": {"@first": "589", "@last": "601"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "W.D.", "@_fa": "true", "ce:surname": "Dupont", "ce:indexed-name": "Dupont W.D."}, {"@seq": "2", "ce:initials": "W.D.", "@_fa": "true", "ce:surname": "Plummer", "ce:suffix": "Jr.", "ce:indexed-name": "Plummer W.D."}]}, "ref-sourcetitle": "Controlled Clinical Trials"}}, {"ref-fulltext": "Cohen, J. Statistical Power Analysis for the Behavioral Sciences. 2nd edn, (Hillsdale, New Jersey: Lawrence Erlbaum Associates, 1988).", "@id": "42", "ref-info": {"ref-publicationyear": {"@first": "1988"}, "refd-itemidlist": {"itemid": {"$": "0003577917", "@idtype": "SGR"}}, "ref-text": "2nd edn, (Hillsdale, New Jersey: Lawrence Erlbaum Associates)", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Cohen", "ce:indexed-name": "Cohen J."}]}, "ref-sourcetitle": "Statistical Power Analysis for the Behavioral Sciences"}}]}}}}, "affiliation": [{"affiliation-city": "Bangkok", "@id": "60028190", "affilname": "Chulalongkorn University", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190", "affiliation-country": "Thailand"}, {"affiliation-city": "Bangkok", "@id": "60022570", "affilname": "Lerdsin Hospital", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022570", "affiliation-country": "Thailand"}, {"affiliation-city": "Bangkok", "@id": "60022183", "affilname": "King Chulalongkorn Memorial Hospital", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183", "affiliation-country": "Thailand"}, {"affiliation-city": "Bangkok", "@id": "60014909", "affilname": "Taksin Hospital", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60014909", "affiliation-country": "Thailand"}], "coredata": {"srctype": "j", "eid": "2-s2.0-85029406786", "dc:description": "Hepatic fibrosis is the net accumulation of matrix tissue components which controlled by pro-fibrolytic enzymes, matrix metalloproteinases (MMPs), and pro-fibrotic cytokine, TGF-\u03b21, and enzymes, tissue inhibitors of MMPs (TIMPs). Vitamin D (VD) supplementation has been shown to reverse these processes in vitro and in vivo. This study sought to determine the effect of VD supplementation on serum fibrotic markers in chronic hepatitis C (CHC) patients. Fifty-four CHC patients with VD deficiency were randomized into two groups, a VD group (n = 29) and a placebo group (n = 29). The serum levels of 25-hydroxy VD, TGF-\u03b21, TIMP-1, MMP2 and MMP9 were measured at baseline and at the end of the 6-week study period. Upon correction of VD levels, TGF-\u03b21 and TIMP-1 levels were decreased, and the MMP2 and MMP9 levels were significantly increased in the VD group. A comparison of the mean changes (delta) in the markers between groups showed that TGF-\u03b21 and TIMP-1 levels were significantly decreased and the MMP2 and MMP9 were significantly higher in the VD group than in the placebo group. By using CHC patients as a model, this study provides additional evidence that VD plays an important role in the reversal of hepatic fibrogenesis.", "pubmed-id": "28827788", "prism:coverDate": "2017-12-01", "prism:aggregationType": "Journal", "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85029406786", "dc:creator": {"author": [{"ce:given-name": "Piyawat", "preferred-name": {"ce:given-name": "Piyawat", "ce:initials": "P.", "ce:surname": "Komolmit", "ce:indexed-name": "Komolmit P."}, "@seq": "1", "ce:initials": "P.", "@_fa": "true", "affiliation": [{"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, {"@id": "60022183", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"}], "ce:surname": "Komolmit", "@auid": "8685320500", "author-url": "https://api.elsevier.com/content/author/author_id/8685320500", "ce:indexed-name": "Komolmit P."}]}, "link": [{"@_fa": "true", "@rel": "self", "@href": "https://api.elsevier.com/content/abstract/scopus_id/85029406786"}, {"@_fa": "true", "@rel": "scopus", "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85029406786&origin=inward"}, {"@_fa": "true", "@rel": "scopus-citedby", "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85029406786&origin=inward"}], "source-id": "21100200805", "citedby-count": "23", "prism:volume": "7", "subtype": "ar", "dc:title": "Vitamin D supplementation improves serum markers associated with hepatic fibrogenesis in chronic hepatitis C patients: A randomized, double-blind, placebo-controlled study", "openaccess": "1", "prism:issn": "20452322", "publishercopyright": "\u00a9 2017 The Author(s).", "article-number": "8905", "prism:issueIdentifier": "1", "subtypeDescription": "Article", "prism:publicationName": "Scientific Reports", "openaccessFlag": "true", "prism:doi": "10.1038/s41598-017-09512-7", "dc:identifier": "SCOPUS_ID:85029406786", "dc:publisher": "Nature Publishing GroupHoundmillsBasingstoke, HampshireRG21 6XS"}, "idxterms": {"mainterm": [{"$": "Adult", "@weight": "b", "@candidate": "n"}, {"$": "Aged", "@weight": "b", "@candidate": "n"}, {"$": "Biomarkers", "@weight": "b", "@candidate": "n"}, {"$": "Dietary Supplements", "@weight": "a", "@candidate": "n"}, {"$": "Female", "@weight": "b", "@candidate": "n"}, {"$": "Genotype", "@weight": "b", "@candidate": "n"}, {"$": "Hepacivirus", "@weight": "b", "@candidate": "n"}, {"$": "Hepatitis C, Chronic", "@weight": "b", "@candidate": "n"}, {"$": "Humans", "@weight": "b", "@candidate": "n"}, {"$": "Liver Cirrhosis", "@weight": "b", "@candidate": "n"}, {"$": "Male", "@weight": "b", "@candidate": "n"}, {"$": "Middle Aged", "@weight": "b", "@candidate": "n"}, {"$": "Transforming Growth Factor beta1", "@weight": "b", "@candidate": "n"}, {"$": "Viral Load", "@weight": "b", "@candidate": "n"}, {"$": "Vitamin D", "@weight": "b", "@candidate": "n"}]}, "language": {"@xml:lang": "eng"}, "authkeywords": null, "subject-areas": {"subject-area": [{"@_fa": "true", "$": "Multidisciplinary", "@code": "1000", "@abbrev": "MULT"}]}, "authors": {"author": [{"ce:given-name": "Piyawat", "preferred-name": {"ce:given-name": "Piyawat", "ce:initials": "P.", "ce:surname": "Komolmit", "ce:indexed-name": "Komolmit P."}, "@seq": "1", "ce:initials": "P.", "@_fa": "true", "affiliation": [{"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, {"@id": "60022183", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"}], "ce:surname": "Komolmit", "@auid": "8685320500", "author-url": "https://api.elsevier.com/content/author/author_id/8685320500", "ce:indexed-name": "Komolmit P."}, {"ce:given-name": "Sayamon", "preferred-name": {"ce:given-name": "Sayamon", "ce:initials": "S.", "ce:surname": "Kimtrakool", "ce:indexed-name": "Kimtrakool S."}, "@seq": "2", "ce:initials": "S.", "@_fa": "true", "affiliation": {"@id": "60022570", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022570"}, "ce:surname": "Kimtrakool", "@auid": "57195642727", "author-url": "https://api.elsevier.com/content/author/author_id/57195642727", "ce:indexed-name": "Kimtrakool S."}, {"ce:given-name": "Sirinporn", "preferred-name": {"ce:given-name": "Sirinporn", "ce:initials": "S.", "ce:surname": "Suksawatamnuay", "ce:indexed-name": "Suksawatamnuay S."}, "@seq": "3", "ce:initials": "S.", "@_fa": "true", "affiliation": [{"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, {"@id": "60022183", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"}], "ce:surname": "Suksawatamnuay", "@auid": "55599677800", "author-url": "https://api.elsevier.com/content/author/author_id/55599677800", "ce:indexed-name": "Suksawatamnuay S."}, {"ce:given-name": "Kessarin", "preferred-name": {"ce:given-name": "Kessarin", "ce:initials": "K.", "ce:surname": "Thanapirom", "ce:indexed-name": "Thanapirom K."}, "@seq": "4", "ce:initials": "K.", "@_fa": "true", "affiliation": [{"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, {"@id": "60022183", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"}], "ce:surname": "Thanapirom", "@auid": "55325142600", "author-url": "https://api.elsevier.com/content/author/author_id/55325142600", "ce:indexed-name": "Thanapirom K."}, {"ce:given-name": "Kanita", "preferred-name": {"ce:given-name": "Kanita", "ce:initials": "K.", "ce:surname": "Chattrasophon", "ce:indexed-name": "Chattrasophon K."}, "@seq": "5", "ce:initials": "K.", "@_fa": "true", "affiliation": {"@id": "60014909", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60014909"}, "ce:surname": "Chattrasophon", "@auid": "57195635953", "author-url": "https://api.elsevier.com/content/author/author_id/57195635953", "ce:indexed-name": "Chattrasophon K."}, {"ce:given-name": "Panarat", "preferred-name": {"ce:given-name": "Panarat", "ce:initials": "P.", "ce:surname": "Thaimai", "ce:indexed-name": "Thaimai P."}, "@seq": "6", "ce:initials": "P.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Thaimai", "@auid": "56904175400", "author-url": "https://api.elsevier.com/content/author/author_id/56904175400", "ce:indexed-name": "Thaimai P."}, {"ce:given-name": "Chintana", "preferred-name": {"ce:given-name": "Chintana", "ce:initials": "C.", "ce:surname": "Chirathaworn", "ce:indexed-name": "Chirathaworn C."}, "@seq": "7", "ce:initials": "C.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Chirathaworn", "@auid": "6603113594", "author-url": "https://api.elsevier.com/content/author/author_id/6603113594", "ce:indexed-name": "Chirathaworn C."}, {"ce:given-name": "Yong", "preferred-name": {"ce:given-name": "Yong", "ce:initials": "Y.", "ce:surname": "Poovorawan", "ce:indexed-name": "Poovorawan Y."}, "@seq": "8", "ce:initials": "Y.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Poovorawan", "@auid": "7102786191", "author-url": "https://api.elsevier.com/content/author/author_id/7102786191", "ce:indexed-name": "Poovorawan Y."}]}}}